Alterity Therapeutics Limited - ADR

Name: Alterity Therapeutics Limited - ADR Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Alterity Therapeutics Limited - ADR

Stock Card

$4.52

$-0.03 (-0.66%)

As on 02-Sep-2026 16:00EDT

Market cap

$82 Mln

Revenue (TTM)

$6 Mln

P/E Ratio

P/B Ratio

2.1

Div. Yield

0 %

Alterity Therapeutics - ADR Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 4.50 High: 4.61

52 Week Range

Low: 2.66 High: 5.89

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.5 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

0.8
Debt to Equity

0
Book Value

$3.4
EPS

$-1
Face value

--
Shares outstanding

18,125,694

10 Years Aggregate

CFO

A$-117.31 Mln

EBITDA

A$-119.26 Mln

Net Profit

A$-107.11 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Alterity Therapeutics - ADR	46.8	2.3	12.5	-8.5	17.8	-19.8	-21.2
BSE Sensex	-9.6	-2.0	3.1	-4.7	5.4	6.0	10.4
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 02-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
Alterity Therapeutics - ADR	-6.9	32.6	-28.5	-51.4	-46.3	71.8	-39.1
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Alterity Therapeutics - ADR	4.5	81.8	5.4	-12.2	-581.6	-43.2	--	2.1
Immuron - ADR (IMRN)	1.2	9.3	7.3	-5.2	-73.9	-50.3	--	1.0
Kazia Therapeutics - ADR	12.6	155.2	0.0	-20.7	-3,568,435.1	226	--	5.8

Shareholding Pattern

View Details

About Alterity Therapeutics - ADR

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug... candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia. Read more

Co-Founder & Non-Executive Chairman

Mr. Geoffrey Paul Kempler B.Sc.
Co-Founder & Non-Executive Chairman

Mr. Geoffrey Paul Kempler B.Sc.
Headquarters

Melbourne, VIC
Website

https://alteritytherapeutics.com

FAQs for Alterity Therapeutics - ADR

What is the current share price of Alterity Therapeutics Limited - ADR Today?

The share price of Alterity Therapeutics Limited - ADR is $4.52 (NASDAQ) as of 02-Sep-2026 16:00 EDT. Alterity Therapeutics Limited - ADR has given a return of 17.8% in the last 3 years.

What is the current PB & PE ratio of Alterity Therapeutics Limited - ADR?

Since, TTM earnings of Alterity Therapeutics Limited - ADR is negative, P/E ratio is not available.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-4.20	1.20
2024	-1.00	1.38
2023	-0.82	0.50
2022	-0.19	0.07
2021	-0.29	0.15

What is the 52 Week High and Low of Alterity Therapeutics Limited - ADR?

The 52-week high and low of Alterity Therapeutics Limited - ADR are Rs 5.89 and Rs 2.66 as of 03-Sep-2026.

What is the market cap of Alterity Therapeutics Limited - ADR?

Alterity Therapeutics Limited - ADR has a market capitalisation of $ 82 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Alterity Therapeutics Limited - ADR?

Before investing in Alterity Therapeutics Limited - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.